Home/Filings/4/0001062993-22-010731
4//SEC Filing

Rareshide Paul 4

Accession 0001062993-22-010731

CIK 0001756497other

Filed

Apr 24, 8:00 PM ET

Accepted

Apr 25, 5:04 PM ET

Size

6.0 KB

Accession

0001062993-22-010731

Insider Transaction Report

Form 4
Period: 2022-04-21
Rareshide Paul
SVP, Corporate Controller
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-04-21+31,60031,600 total
    Exercise: $18.99Exp: 2028-01-30Common Stock (31,600 underlying)
Footnotes (1)
  • [F1]Reflects a January 30, 2018 option grant (the "2018 Option Grant") which was previously not required to be reported as a derivative security. On April 21, 2022, the Company approved an additional service-based vesting opportunity for the options. Options to vest in three equal annual installments, subject to the Reporting Person's continued employment through the applicable vesting date, commencing upon the earlier to occur of: (a) affiliates of Blackstone Inc. selling more than 25% of the equity interests of the Company (the "Exit Event") or (b) June 30, 2022. Any options outstanding under 2018 Option Grant will fully vest and become exercisable upon an Exit Event in which the equity interests are sold at a weighted average price in excess of $33.23 per share.

Issuer

Change Healthcare Inc.

CIK 0001756497

Entity typeother

Related Parties

1
  • filerCIK 0001778337

Filing Metadata

Form type
4
Filed
Apr 24, 8:00 PM ET
Accepted
Apr 25, 5:04 PM ET
Size
6.0 KB